<DOC>
	<DOC>NCT01891578</DOC>
	<brief_summary>Evaluation of immunological reconstitution after haploidentical BMT using a nonmyeloablative preparative regimen and post-transplant cyclophosphamide in patients with poor prognosis lymphoma</brief_summary>
	<brief_title>Evaluation of Immunological Reconstitution After Haploidentical Bone Marrow Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<criteria>Patients with lymphoma (any histology) relapsed after high dose chemotherapy and in partial remission, complete remission or stable disease after the last CT line that Signed informed consent to perform an haploidentical alloBMT using a nonmyeloablative preparative regimen and posttransplant cyclophosphamide</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>